SEELOS THERAPEUTICS, INC.

/SEELOS THERAPEUTICS, INC.

We are a clinical-stage biopharmaceutical company focused on achieving efficient development of products that address significant unmet needs in Central Nervous System ("CNS") disorders and other rare disorders.

Symbol

Last Closing Price
$0.86

Shares
5,000,000

Anticipated Date
March 12, 2020

Underwriters

This offering is no longer available

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange